Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Editor's Picks
6/15/2023
Health Technology Assessment to Inform Decision Making in China: Progr...
6/15/2023
Use of Real-World Data to Improve Drug Coverage Decisions in China (BM...
6/15/2023
How Health Technology Reassessment Can Support Disinvestment in China'...
6/13/2023
Responding to Challenges in the Chinese Healthcare Market Volume Based...
6/12/2023
Understanding China's Rapidly Growing Healthcare Market (China Briefin...
6/12/2023
China Wakes Up to Danger From Illegal Lab Monkey Trade (Sixth Tone)
6/12/2023
China's Growth as Pharmaceutical Hub for APIs to Continue (BioSpectrum...
6/9/2023
May Was a Big Month for Oncology Therapies in China (PharmaDJ)
6/8/2023
How China's Detailed Human Genetic Resources Rules May Impact MNC Life...
6/7/2023
Chinese Drugmakers Seek to Emulate the Success of Novo Nordisk's Wegov...
6/5/2023
British Businesses in China: Conditionally Optimistic for 2023 (China ...
6/5/2023
AstraZeneca Defies Geopolitics to Bet on China (FT)
6/5/2023
China Races into New-Generation Obesity Drug Arena with Potential Asse...
6/1/2023
The U.S.-Chinese Economic Relationship Is Changing—But Not Vanishing ...
5/30/2023
China is in Danger of Growing Far Below its Potential (The Market NZZ)
5/29/2023
National Value-based Pricing Negotiation for Oncology Drugs — Lessons...
5/29/2023
April Sees Deals Worth $2.8B in ADCs, CAR-T Therapies and More (Pharma...
5/26/2023
China's Souped-up Data Privacy Laws Deter Researchers (Nature)
5/26/2023
China's Middle Class – Growth, Policy, and Consumption (China Briefin...
5/22/2023
Doctor-influencers Ae Going Viral in China, Provoking Authorities (ROW...
5/19/2023
An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...
5/19/2023
April Fundraising Rebounds with $315M Capital Injection to Hasten Biop...
5/19/2023
CStone Breaks Up With Drugs Partner As U.S. Rollout Stalls (Bamboo Wor...
5/16/2023
China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...
5/15/2023
China's $220 Billion Biotech Initiative Is Struggling to Take Off (Blo...
5/12/2023
How China's Population Decline Will Impact Doing Business in the Count...
5/11/2023
Lilly Migraine Deal Gives AffaMed New Mojo in Changing China: Video In...
5/11/2023
Ethical Review of Science and Technology in China: Draft Trial Measure...
5/9/2023
2023Q1 China Biopharma Ventures, IPOs and Deals (PharmaDJ)
5/5/2023
Reshoring and Nearshoring – Is China Still Relevant? (TMD)
Page:
6
/
7
Total number of articles:
182
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit